Ebola in eastern DRC

The Lancet Infectious Diseases

Volumn 19, Issue 10, 2019, Pages 1049-1050

  Rollin, Pierre E ^a  

^a Lilburn   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEMOCRATIC REPUBLIC CONGO; EBOLA HEMORRHAGIC FEVER; FOLLOW UP; HEALTH CARE PERSONNEL; HUMAN; INFECTION PREVENTION; LABORATORY DIAGNOSIS; MOLECULAR TYPING; NATIONAL HEALTH ORGANIZATION; NOTE; PRIORITY JOURNAL; QUALITY CONTROL PROCEDURES; VACCINATION; EBOLAVIRUS; ENDEMIC DISEASE; EPIDEMIC; IMMUNOLOGY; POINT OF CARE SYSTEM; PROCEDURES; VIROLOGY;

EBOLA VACCINE;

DEMOCRATIC REPUBLIC OF THE CONGO; DISEASE OUTBREAKS; EBOLA VACCINES; EBOLAVIRUS; ENDEMIC DISEASES; HEALTH PERSONNEL; HEMORRHAGIC FEVER, EBOLA; HUMANS; POINT-OF-CARE SYSTEMS; VACCINATION;

EID: 85070210895     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(19)30422-0     Document Type: Note

References (4)

1. WHO Regional Office for Africa. Ebola virus disease. Democratic Republic of the Congo. External situation report 52. Geneva: World Health Organization, July 30, 2019. https://www.who.int/publications-detail/ebola-virus-disease-democratic-republic-of-congo-external-situation-report-52-2019. (accessed July 31, 2019).
2. Ilunga Kalenga O, Moeti M, Sparrow A, Nguyen VK, Lucey D, Ghebreyesus TA. The ongoing Ebola epidemic in the Democratic Republic of Congo, 2018–2019. N Engl J Med 2019; 381: 373–83.
3. WHO. Notes for the record: consultation on monitored emergency use of unregistered and investigational interventions (MEURI) for Ebola virus disease (EVD). Geneva: World Health Organization, Aug 27, 2018. https://www.who.int/ebola/drc-2018/notes-for-the-record-meuri-ebola.pdf (accessed July 29, 2019).
4. Nakkazi E. Randomised controlled trial begins for Ebola therapeutics. Lancet 2018; 392: 2338.